Members ofthe Alliance Aviesan's CVT and Technology Transfer Acceleration Companies are joining forces in the field of epigenetics applied to cancer, in order to promote the transfer of public research results to the biomedical industry.
Our Call for Expressions of Interest (CEI) aims to be the first step in a process of project development, construction, expertise, and financing. Eligible expressions of interest include proof of concept related to therapies (new molecules, new targets) and diagnostics (biomarkers and companion tests), whether or not supported by research tools (animal models, study methods, etc.).
This initiative is open to all national academic teams. It will enable synergies to be identified between research teams working on this topic. Projects may therefore emerge independently, or combine the technological building blocks of several teams at the national level working in different disciplines (bioinformatics, chemistry, biology, clinical science, etc.).